Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ya. I. Bondarchuk"'
Autor:
D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, E. K. Zhiltsova, R. V. Donskikh, A. P. Sokolenko, L. F. Shaykhelislamova, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, S. S. Ereshchenko, R. M. Paltuev, A. A. Bessonov, A. S. Artemyeva, R. S. Pesotskiy, N. S. Amirov, A. S. Emelyanov, V. V. Mortada, Ya. I. Bondarchuk, V. V. Semiglazov, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 48-55 (2023)
Background. BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in finding new treatment options for patients
Externí odkaz:
https://doaj.org/article/f7969acdde894223bd4331d72b66866d
Autor:
Ya. I. Bondarchuk, E. K. Zhiltsova, P. V. Krivorotko, R. S. Pesotskiy, A. S. Emelyanov, T. T. Tabagua, L. P. Gigolaeva, S. S. Yereshchenko, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, V. V. Semiglazov, R. M. Paltuev, V. V. Mortada, L. F. Shaykhelislamova, D. A. Enaldieva, N. S. Amirov, V. S. Channov, A. S. Artemyeva, A. V. Chernaya, R. Kh. Ulyanova, V. F. Semiglazov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 4, Pp 43-51 (2023)
Background. Surgery is fundamental in complex and combined approach in the treatment of the early breast cancer. It is a common fact, that absence of tumor cells in the resection margin is the main indicator of oncological safety of the breast-conser
Externí odkaz:
https://doaj.org/article/b0b1ea7f79e54b3197715ab491a1c07a
Autor:
P. V. Krivorotko, V. V. Mortada, R. S. Pesotskiy, A. S. Artemyeva, A. S. Emelyanov, S. S. Ereshchenko, G. A. Dashyan, N. S. Amirov, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, M. M. Mortada, K. Yu. Zernov, E. K. Zhiltsova, V. O. Smirnova, Ya. I. Bondarchuk, D. A. Enaldieva, S. N. Novikov, E. A. Busko, A. V. Chernaya, P. I. Krzhivitskiy, R. M. Paltuev, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 29-39 (2022)
Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and overall survival. In triple negative (TN) and HER2-positive breast cancer (BC), the pCR rate exc
Externí odkaz:
https://doaj.org/article/1dba194b85a7496f8bacea07c8744896
Autor:
E. A. Busko, V. V. Mortada, P. V. Krivorotko, V. F. Semiglazov, R. S. Pesotsky, А. S. Emelyanov, N. S. Amirov, V. S. Channov, T. T. Tabagua, L. P. Gigolaeva, S. S. Yerechshenko, A. V. Komyakhov, K. S. Nikolaev, K. Y. Zernov, E. K. Zhiltsova, Ya. I. Bondarchuk, D. A.. Enaldieva, S. N. Novikov, V. S. Apollonova, A. I. Tseluiko, B. S. Kasparov
Publikováno v:
Diagnostic radiology and radiotherapy. 13:43-50
INTRODUCTION: Introduction of breast cancer screening programs has led to an increase in detection of non-palpable masses requiring core needle biopsy. Masses that fall into B3 category based on the histological results of core biopsy specimens, are